She joined Proctor and Gamble in the US in a research role with their newly acquired pharmaceutical division, Norwich Eaton Pharmaceuticals. After transferring back to Canada with P&G to set up a similar division, she joined Apotex, the largest Canadian generic pharmaceutical company to establish a similar Drug Information and Adverse Event Reporting division. While at Apotex, Terri not only set up a new division for Apotex but was awarded the only accreditation status in Canada for a manufacturer-run DI service.
She went on to join the sales team at Apotex, rising to an executive position before leaving to establish a new Pharmacy Relations Division at Wyeth Pharmaceuticals. While at Wyeth, Terri managed to increase the Pharmacy Relations score at the Advantage Group Survey from 15th to a fifth rank position within the industry.
From there, Terri joined Sandoz in Montreal where she lead the Sale and Marketing Divisions. Prior to taking on the Chief Commercial Officer position at TH!NK BI, Terri was responsible for the Generic Division at IMS Brogan; re-establishing IMS Brogan in the generic space.